Crohn disease arthropathy: Antigens in synovial fluid share epitopes with strains of two species of viridans streptococci

Scandinavian Journal of Gastroenterology

Volumn 35, Issue 3, 2000, Pages 287-292

  Baker, S J ^a,b   Jacob, E ^a   Bowden, G H ^a  

^a Department of Restorative Dentistry Faculty of Health Sciences College of Dentistry   (Canada)

^b ST BONIFACE GENERAL HOSPITAL   (Canada)

Author keywords

Antibodies; Antigens; Arthritis, reactive; Bacterial; Crohn disease; Hypersensitivity, delayed; Streptococcus oralis; Streptococcus parasanguis; Synovial fluid; Viridans streptococci

Indexed keywords

BACTERIAL ANTIGEN; EPITOPE;

ADULT; ALPHA HEMOLYTIC STREPTOCOCCUS; ANTIGEN EXPRESSION; ARTHROPATHY; ARTICLE; BACTERIUM CULTURE; BACTERIUM ISOLATION; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CROHN DISEASE; FEMALE; HUMAN; IMMUNE RESPONSE; MALE; PRIORITY JOURNAL; REACTIVE ARTHRITIS; STOMACH JUICE; STREPTOCOCCUS ORALIS; STREPTOCOCCUS PARASANGUINIS; SYNOVIAL FLUID; YERSINIOSIS;

EID: 0034005835     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.1080/003655200750024164     Document Type: Article

References (42)

1. 1. Crohn BB, Ginzburg L, Oppenheimer CD. Regional ileitis: a pathologic and clinical entity. JAMA 1932;99:1323-9.
2. 2. Sartor RB. Current concepts of the etiology and pathogenesis of ulcerative colitis and Crohn's disease. Gastroenterol Clin North Am 1995;24:475-507.
3. 3. Hadden JW, Smithyman AM, Warfel AH. Mechanisms of granuloma formation. In: Safai B, Good RA, editors. Comprehensive immunology. 7. Immuno-dermatology. London: Plenum; 1981. p. 449-65.
4. 4. Janowitz HD, Croen EC, Sachar DB. The role of the fecal stream in Crohn's disease: an historical and analytical review. Inflamm Bowel Dis 1988;4:29-39.
5. 5. Harper PH, Lee ECG, Kettlewell MGW, Jewell DP. Role of the faecal stream in the maintenance of Crohn's colitis. Gut 1985; 26:279-84.
6. 6. Morson BC. Pathology of Crohn's disease. Clin Gastroenterol 1972;1:265-77.
7. 7. Rickert RR, Carter HW. The 'early' ulcerative lesions of Crohn's disease: correlative light-and scanning electron-microscopic studies. J Clin Gastroenterol 1980;2:11-9.
8. 8. Owen RL, Jones AL. Epithelial cell specialization within human Peyer's patches: an ultrastructural study of intestinal lymphoid follicles. Gastroenterology 1974;66:189-203.
9. 9. Jacob E, Baker SJ, Swaminathan SP. 'M' cells in the follicle-associated epithelium of the human colon. Histopathology 1987; 11:941-52.
10. 10. Gorbach SL. Intestinal microflora. Gastroenterology 1971;60: 1110-29.
11. 11. Lahesmaa-Rantala R, Granfors K, Isomäki H, Toivanen A. Yersinia specific immune complexes in the synovial fluid of patients with yersinia triggered reactive arthritis. Ann Rheum Dis 1987;46:510-4.
12. 12. Greenstein AJ, Junowitz HD, Sachar DB. The extra-intestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine (Baltimore) 1976;55:401-12.
13. 13. Hannestad K. Presence of aggregated τG-globulin in certain rheumatoid synovial effusions. Clin Exp Immunol 1967;2:511-29.
14. 14. Creighton WD, Lambert PH, Miescher PA. Detection of antibodies and soluble antigen-antibody complexes by precipitation with polyethylene glycol. J Immunol 1973;111:1219-27.
15. 15. Affinity chromatography: principles and methods. Lund, Sweden: Pharmacia Fine Chemicals; 1974.
16. 16. Bank RA, Hettama EH, Arwert F, Amerongen AVN, Pronk JC. Electrophoretic characterization of posttranslational modifications of human parotid salivary α-amylase. Electrophoresis 1991;12:74-9.
17. 17. Laemmli UK. Cleavage of structural proteins during the assembly of the head bacteriophage T4. Nature 1970;277:680-5.
18. 18. Towbin H, Staehelin T, Gordon J. Electrophoretic transfer of proteins from polyaerylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979:76:4350-4.
19. 19. Dunbar BS Two dimensional electrophoresis and immunological techniques. New York: Plenum; 1987.
20. 20. Beighton D, Hardie JM, Whiley RA. A scheme for the identification of viridans streptococci. J Med Microbiol 1991;35: 367-72.
21. 21. Tabaqchali S, O'Donoghue DP, Bettelheim KA. Escherichia coli antibodies in patients with inflammatory bowel disease. Gut 1978;19:108-13.
22. 22. Matthews N, Mayberry JF, Rhodes J, Neale L, Munro J, Wensinck F, et al. Agglutinins to bacteria in Crohn's disease. Gut 1980:21:376-80.
23. 23. Blaser MJ, Miller RA, Lacher J, Singleton JW. Patients with active Crohn's disease have elevated scrum antibodies to antigens of seven enteric bacterial pathogens. Gastroenterology 1984;87:888-94.
24. 24. Olaison G. Abnormal intestinal permeability in Crohn's disease. Scand J Gastroenterol 1990;25:321-8.
25. 25. Cartun RW, van Kruiningen HJ, Pederson CA, Berman MM. An immunocytochemical search for infectious agents in Crohn's disease. Mod Pathol 1993;6:212-9.
26. 26. Liu Y, van Kruiningen HJ, West AB, Cartun RW, Cortot A, Colombel JF. Immunocytochemical evidence of Listeria, Escherichia coli, and Streptococcus antigens in Crohn's disease. Gastroenterology 1995; 108:1396-404.
27. 27. Tappuni AR, Challacombe SJ. Distribution and isolation frequency of eight streptococcal species in saliva from predentate and dentate children and adults. J Dent Res 1993;72:31-6.
28. 28. Pearce C, Bowden GH, Evans M, Fitzsimmons SP, Johnson J, Sheridan MJ, et al. Identification of pioneer viridans streptococci in the oral cavity of human neonates. J Med Microbiol 1995;42: 67-72.
29. 29. Peach S, Lock MR, Katz D, Todd IP, Tabaqchali S. Mucosal-associated bacterial flora of the intestine in patients with Crohn's disease and in a control group. Gut 1978;19:1034-42.
30. 30. Forcione DG, Sands B, Isselbacher KJ, Rustgi A, Podolsky DK, Pillai S. An increased risk of Crohn's disease in individuals who inherit the HLA class II DRB3*0301 allele. Proc Natl Acad Sci USA 1996;93:5094-8.
31. 31. Lopez-Cubero SO, Sullivan KM, McDonald GB. Course of Crohn's disease after allogenic marrow transplantation. Gastroenterology 1998;114:433-40.
32. 32. Kashyap P, Forman SJ. Autologous bone marrow transplantation for non-Hodgkins lymphoma resulting in long-term remission of coincidental Crohn's disease. Br J Haematol 1998;103:651-2.
33. 33. Mowat AM. Oral tolerance and regulation of immunity to dietary antigens. In: Ogra PL, editor. Handbook of mucosal immunology. San Diego (CA): Academic Press; 1994. p. 185-201.
34. 34. Gent AE, Hellier MD, Grace RH, Swarbrick ET, Coggon D. Inflammatory bowel disease and domestic hygiene in infancy. Lancet 1994;343:766-7.
35. 35. Camoglio L, Te Velde AA, Tiggs AJ, Das PK, Van Deventer SJH. Altered expression of interferon-gamma and interleukin-4 in inflammatory bowel disease. Inflamm Bowel Dis 1988:4:285-90.
36. 36. Moss AA, Carbone JV, Kressel HY. Radiological and clinical assessment of broad-spectrum antibiotic therapy in Crohn's disease. Am J Roentgenol 1978;131:787-90.
37. 37. Peppercorn MA. Is there a role for antibiotics as primary therapy in Crohn's ileitis? J Clin Gastroenterol 1993;17:235-7.
38. 38. van Kruiningen HJ. On the use of antibiotics in Crohn's disease. J Clin Gastroenterol 1995;20:310-6.
39. 39. Wolf JL. Ciprofloxacin may be useful in Crohn's disease. Gastroenterology 1990;98:A212.
40. 40. Gui GP, Thomas PR, Tizard ML, Lake J, Sanderson JD, Hermon-Taylor J. Two-year-outcomes analysis of Crohn's disease treated with rifabutin and macrolid antibiotics. J Antimicrob Chemother 1997;39:393-400.
41. 4L Greenbloom SL, Steinhart AH, Greenberg GR. Combination ciprofloxacin and metronidazole for active Crohn's disease. Can J Gastroenterol 1998;12:53-6.
42. 42. Prantcra MD, Zannoni F, Scribano ML, Berto E, Andreoli A, Kohn A, et al. An antibiotic regimen for the treatment of active Crohn's disease: a randomized, controlled clinical trial of metronidazole plus ciprofloxacin. Am J Gastroenterol 1996;91: 328-32.